|Articles|May 31, 2016
Quintiles Introduces Precision Enrollment Offering
Quintiles announces its Precision Enrollment offering to accelerate site start-up and patient recruitment in oncology clinical trials.
Advertisement
Quintiles announces its Precision Enrollment offering to accelerate site start-up and patient recruitment in oncology clinical trials. This new model adjusts the traditional site start-up pathway so that it is only opened after a patient is identified.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clarifying Ownership of IRT Data in Clinical Trials: Distinguishing Investigator-Controlled Data from Sponsor Operational Data
2
ACT Brief: Support Services and Cancer Trial Access, 2025’s Most-Watched ACT Video Interviews, and FDA Approval of Narsoplimab
3
Measuring Barriers to Improve Enrollment and Retention
4